共 34 条
- [21] Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (05): : 462 - 464
- [30] Consider clinically relevant pharmacokinetic drug interactions when co-prescribing drugs in attention-deficit/hyperactivity disorder Drugs & Therapy Perspectives, 2020, 36 : 386 - 388